Sidley advised Outset Medical Inc. (NASDAQ: OM), a private equity-backed medical technology company focused on an innovative dialysis solution, in connection with its initial public offering, which was upsized to nearly US$278 million (including green shoe). Outset Medical sold 8.95 million shares in the offering at US$27 per share, pricing well above its disclosed range of US$22 to US$24 per share, and more than doubling in price in subsequent trading on NASDAQ. The transaction ranks among the largest recent medical technology company initial public offerings.  Learn more here.

See all Member News